We appreciate your patience with any delays in shipment during pandemic.

My Account Shopping Cart Email Us Call Us
Home > FAQ and Resources > Research Using Cospheric Spheres > Research With Polyethylene Microspheres > Mechanisms of Exercise-Induced Amelioration of Cardiovascular Disease

Mechanisms of Exercise-Induced Amelioration of Cardiovascular Disease

Mechanisms of Exercise-Induced Amelioration of Cardiovascular Disease

Am J Physiol Heart Circ Physiol314: H627–H642, 2018.First published November 22, 2017; doi:10.1152/ajpheart.00380.2017

Kelly Stam, Richard W. B. van Duin, André Uitterdijk, Zongye Cai, Dirk J. Duncker, and Daphne Merkus

Fluorescent Blue Polyethylene microspheres: 600-710um

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) develops in 4% of patients after pulmonary embolism and is accompanied by an impaired exercise tolerance, which is ascribed to the increased right ventricular (RV) afterload in combination with a ventilation/perfusion (V/Q) mismatch in the lungs. The present study aimed to investigate changes in arterial Po2 and hemodynamics in response to graded treadmill exercise during development and progression of CTEPH in a novel swine model. Swine were chronically instrumented and received multiple pulmonary embolisms by 1) microsphere infusion (Spheres) over 5 wk, 2) endothelial dysfunction by administration of the endothelial nitric oxide synthase inhibitor N?-nitro-l-arginine methyl ester (L-NAME) for 7 wk, 3) combined pulmonary embolisms and endothelial dysfunction (L-NAME + Spheres), or 4) served as sham-operated controls (sham). After a 9 wk followup, embolization combined with endothelial dysfunction resulted in CTEPH, as evidenced by mean pulmonary artery pressures of 39.5 ± 5.1 vs. 19.1 ± 1.5 mmHg (Spheres, P < 0.001), 22.7 ± 2.0 mmHg (L-NAME, P < 0.001), and 20.1 ± 1.5 mmHg (sham, P < 0.001), and a decrease in arterial Po2 that was exacerbated during exercise, indicating V/Q mismatch. RV dysfunction was present after 5 wk of embolization, both at rest (trend toward increased RV end-systolic lumen area, P = 0.085, and decreased stroke volume index, P = 0.042) and during exercise (decreased stroke volume index vs. control, P = 0.040). With sustained pulmonary hypertension, RV hypertrophy (Fulton index P = 0.022) improved RV function at rest and during exercise, but this improvement was insufficient in CTEPH swine to result in an exercise-induced increase in cardiac index. In conclusion, embolization in combination with endothelial dysfunction results in CTEPH in swine. Exercise increased RV afterload, exacerbated the V/Q mismatch, and unmasked RV dysfunction.NEW & NOTEWORTHY Here, we present the first double-hit chronic thromboembolic pulmonary hypertension swine model. We show that embolization as well as endothelial dysfunction is required to induce sustained pulmonary hypertension, which is accompanied by altered exercise hemodynamics and an exacerbated ventilation/perfusion mismatch during exercise.Here, we present the first double-hit chronic thromboembolic pulmonary hypertension swine model. We show that embolization as well as endothelial dysfunction is required to induce sustained pulmonary hypertension, which is accompanied by altered exercise hemodynamics and an exacerbated ventilation/perfusion mismatch during exercise.


Connect with us:

Facebook Twitter LinkedIn

We are here for you!

Do you have questions about our products? Need help with product selection?
Contact our technical support team at support@cospheric.com.

Sales inquiries?

Reach out to customer service at info@cospheric.com or +1-805-687-3747


Order online anytime

Check out online with a credit card or email a purchase order to info@cospheric.com

About the Company:

Cospheric is a global leader in manufacturing and distribution of precision nanospheres, microspheres, and larger precision spherical particles. Scientists and engineers worldwide rely on us as a proven source to fulfill their needs for microparticles in narrow size ranges, wide selection of colors, densities, properties and formulations. We leverage our extensive technical expertise in micropowders to help each customer find an optimal microparticle solution for their needs. We ship worldwide daily out of our Santa Barbara, CA manufacturing facility.
Terms and ConditionsPrivacy Policy
Cospheric LLC - the leading global supplier of precision spherical particles | Manufactured in Santa Barbara, CA, USA
Copyright © 2008-2020 Cospheric LLC. All Rights Reserved.